OnKure Therapeutics Inc. (OKUR)
NASDAQ: OKUR
· Real-Time Price · USD
2.49
-0.11 (-4.23%)
At close: Jun 17, 2025, 2:12 PM
-4.23% (1D)
| Bid | 2.44 |
| Market Cap | 33.64M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -68.95M |
| EPS (ttm) | -4.39 |
| PE Ratio (ttm) | -0.57 |
| Forward PE | -0.76 |
| Analyst | Buy |
| Ask | 2.58 |
| Volume | 99,431 |
| Avg. Volume (20D) | 150,100 |
| Open | 2.61 |
| Previous Close | 2.60 |
| Day's Range | 2.41 - 2.67 |
| 52-Week Range | 1.70 - 20.00 |
| Beta | 0.42 |
About OKUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OKUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OKUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
7 months ago · seekingalpha.com
OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And BeyondInitial OnKure Therapeutics, Inc. data from the phase 1 PIKture-01 study, using OKI-219 for the treatment of patients with PI3Ka-H1047R breast cancer and solid tumors, is expected in Q4 of 2024. OKI-2...